Gilles Spenlehauer

OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT.

AARP, Inc. (District of Columbia) provides general, legal information and products and facilities to aged citizens. It offers discounts, insurance, financial, health products, travel benefits to its members. The company was founded by Ethel Percy Andrus in 1958 and is headquartered in Washington, DC.

Morgan Stanley Investment Management Pvt Ltd. (India) (MSIM), founded in 1993, is an asset management subsidiary of Morgan Stanley (NYSE: MS). The firm specializes in managing assets for a range of institutional clients, including endowments, foundations, pension funds, corporations, governments, and high-net worth individuals. The Mumbai office focuses on managing portfolios of Indian securities. MSIM has offices in New York, Philadelphia, Houston, Chicago, London, Tokyo, Amsterdam and Singapore.

ICICI Venture Funds Management Co. Ltd (ICICI) is a Private Equity firm, a subsidiary of ICICI Bank Ltd. founded in 1988. The firm is headquartered in India.

Malladi Drugs & Pharmaceuticals Ltd. manufactures active pharmaceutical ingredients. It manufactures Ephedrine and Pseudo-Ephedrine. The firm's products include active pharmaceutical ingredients, intermediates and speciality products,and chiral building blocks and speciality chemicals. Its services include contract manufacturing, custom synthesis and contract research. The company was founded by M. L. N. Satry in 1980 and is headquartered in Chennai, India.

The Indian Institute of Technology, Madras, is among the foremost of institutes of national importance in higher technological education and in basic and applied research. The Institute, with nearly 360 faculty, 4000 students, 1250 administrative and supporting staff, is a self-contained campus and is located in a beautiful, wooded land of about 250 hectares in South Madras

Founded in 1990 by Liam Dalton, Axiom Capital Management, Inc. is a full-service broker/dealer located in New York City. The firm offers traditional fixed-income and equity services including separately managed accounts through mutual funds, hedge funds, fund of funds and exchange funds. They serve high net-worth individuals, pension plans, profit sharing plans and other institutions. Axiom Capital Management is member of FINRA/SIPC. Axiom assists start-up and transitional hedge funds in selecting the prime broker best suited for their funds. The firm's services include: soft dollar reimbursements, execution of foreign market derivatives, turnkey information technology infrastructure solutions. Axiom can meet the needs of hedge funds worth up to $1 billion. Axiom is an experienced soft-dollar broker. The firm works their large, diverse institutional customer base to arrange equitable and compliant soft-dollar agreements. The firm's trading desk adheres to the highest compliance standards combining state-of-the-art technology and experienced traders to deliver quality executions in most domestic and international products.

Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA

Avantor Performance Materials India Ltd. manufactures and distributes pharmaceutical products. Its products include acids, amino acids, aqueous solutions, biological regents and denaturants. The company was founded by John Townsend Baker in 1904 and is headquartered in Gurgaon, India.

Arch Pharmalabs Ltd. manufactures and sells pharmaceutical products. Its therapeutic segments include side chains of Semi-Synthetic Isoxazole Penicillins under Antibiotics, Lipid Lowering Agents, Oncology, Anti-Platelet Agents, Anti-Asthmatic, Anti-Retroviral, Decongestant, Anti-Herpes, Anti-Malarial, NSAIDs and Anti-Anginal segments. The company was founded in 1975 and is headquartered in Mumbai, India.

Unimark Remedies Ltd. develops and markets active generic medicines. It specializes in pharmaceutical products for respiratory, cardiovascular, anti-infectives, and central nervous system. The company was founded in 1982 and is headquartered in Mumbai, India.

Avendus Capital Pvt Ltd. provides financial services. The firm offers financial advisory, mergers and acquisitions, private equity syndication, equity capital markets, structured finance, financial sponsors group, wealth management, alternative asset management, and institutional equities. The company was founded by Ranu Vohra, Gaurav Deepak and Kaushal Aggarwal and is headquartered in Mumbai, India.

Bharat Biotech International Ltd. engages in research and development, manufacturing, marketing and distribution of vaccines and biotherapeutics. It focuses on the development of novel health care solutions for region-specific neglected diseases. The firm offers Revac-B+, REGEN-D, HNVAC, COMVAC5, BIOPOLIO, INDIRAB, Typbar TCV, BIOHIB, JENVAC, ROTAVAC and vaccine candidates against chikungunya, chandipura, HPV and Ebola. The company was founded by Krishna Murthy Ella and Suchitra K. Ella in 1996 and is headquartered in Hyderabad, India..

Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA.

I-VEN Medicare India Pvt Ltd. provides investment services in the healthcare sectors. It invests in hospitals and research institutes. The company is headquartered in Bangalore, India.

Teva Pharmaceuticals Ltd. manufactures pharmaceutical products. The company was incorporated on October 19, 1972 and is headquartered in Castleford, the United Kingdom.

Medicinal Genomics Corp. engages in the provision of genetics-based cannabis testing and breeding technologies. It offers microbial testing, strain identification and registration, and point-of-grow screening cannabis solutions. The company was founded by Kevin J. McKernan in 2011 and is headquartered in Beverly, MA.

Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom.

Kg Biopharma Consulting LLC provides strategic advisory services. The private company is based in Wilton, CT.

InflammX Therapeutics, Inc. is a biopharmaceutical company that focuses on targeting the NLRP3 inflammasome pathway of inflammation. The private company is based in Tampa, FL. The company has identified the key disease-related upstream trigger for inflammasome activation and its therapeutics target this trigger. Its lead product, Xiflam™, is set to enter phase 2b clinical trials in the fourth quarter of 2022. In addition, InflammX has a follow-on pre-clinical peptide program that also targets the dysregulated NLRP3 inflammasome, which will be developed following additional funding being raised. The company was founded by Colin Richard Green, and the CEO is Brian Levy.

Anuncia, Inc. develops neuro therapeutic devices. The American company was founded in 2018. Elsa Chi Abruzzo has been the CEO of the company since 2018.